AI Insights · Timothy · July 2024
Top Medical Apps on iOS in Greece Q2 2024
In Q2 2024, the top medical apps in Greece on iOS showed varied performance in terms of downloads, revenue, and active users. Key insights into these trends are highlighted below.
In Q2 2024, the top medical apps on the iOS platform in Greece exhibited diverse trends in downloads, revenue, and active user metrics. Here’s a detailed look at the performance of the leading apps in this category, based on data from Sensor Tower.
MyHealth saw a fluctuating trend in weekly downloads, starting with 1.4K downloads in the first week of April and ending with 1.2K downloads by the last week of June. The highest download peak was observed in the second week of April with 1.5K downloads. Throughout the quarter, the app did not generate any revenue.
Pregnancy Tracker - BabyInside experienced varied weekly download numbers, beginning with 357 downloads in early April and reaching 334 downloads by the end of June. The highest download count was 396 in the last week of May. Revenue for this app showed an upward trend, peaking at $90 in mid-June. Weekly active users ranged from 4.9K to 5.9K, with the highest number recorded in the last week of June.
Doctoranytime, which launched in April 2024, had a consistent download performance, ranging from 210 to 308 downloads per week. This app did not generate any revenue during the quarter.
Pregnancy + | Tracker App displayed a stable trend in weekly downloads, starting at 291 and peaking at 336 downloads by the end of June. Revenue for this app varied, with a peak of $24 in mid-May. Active user numbers fluctuated between 7.8K and 8.9K, with the highest number in the last week of June.
my-Ygeia had a moderate download performance, beginning with 330 downloads in the first week of April and ending with 226 downloads by the last week of June. The highest download count was 330 at the start of the quarter. This app did not generate any revenue throughout the period.
For more detailed insights and data, visit Sensor Tower.